Co-investigator NCRN investigator led clinical trial: RomiCar - Phase I/II study to determine the maximum tolerated dose and activity of the combination of romidepsin and carfilzomib in relapsed or refractory peripheral T-cell lymphoma
- Kim Linton (Other)
Activity: Internal positions, career professional development, other peer review and other › Other › Research